Evidence map›Paper›PMID 24887233›Full record

ArticleBlood transfusion = Trasfusione del sangue2014

Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy.

Donatella Venturelli, Mariachiara Lodi, Giovanni Palazzi, Giuliano Bergonzini, Giada Doretto, Annalisa Zini, Cellini Monica, M Carmen Cano, Mariotti Ilaria, Giuliano Montagnani and 1 more

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Newborn Screening for Sickle Cell Disease in Europe.International journal of neonatal screening · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Donatella VenturelliTransfusion Medicine Department, University Hospital of Modena, Modena, Italy.
Mariachiara LodiDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
Giovanni PalazziDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
Giuliano BergonziniLaboratory Medicine Department, University Hospital of Modena, Modena, Italy.
Giada DorettoTransfusion Medicine Department, University Hospital of Modena, Modena, Italy.
Annalisa ZiniDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
Cellini MonicaDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
M Carmen CanoDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
Mariotti IlariaDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
Giuliano MontagnaniTransfusion Medicine Department, University Hospital of Modena, Modena, Italy.
Paolo PaolucciDepartment of Mother and Child, University Hospital of Modena, Modena, Italy.
University of Modena and Reggio Emilia · ITAzienda Unita' Sanitaria Locale Di Modena · ITNational Operating Committee on Standards for Athletic Equipment · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrom 2005 to 2010, we observed a 10-fold increase of newly diagnosed sickle cell disease in children in the province of Modena (northern Italy). The median age at diagnosis was 24 months. Since these children are too old for optimal disease management, earlier detection of the disease is needed for prophylaxis and comprehensive care before the occurrence of clinical manifestations. MATERIALS AND

methodsIn each Maternity Unit of the province of Modena, blood samples are collected daily for assessment of haemolytic disease of the newborn. We designed a selective, low-cost haemoglobin screening for sickle cell disease in high-risk immigrants. We enrolled 469 mothers from sub-Saharan countries and their neonates for a primary screening of peripheral blood haemoglobin variants using high-performance liquid chromatography.

resultsOf the 469 women approached, 330 (70.36%) agreed to undergo the test. Ninety-two (27.88%) were carriers of variant haemoglobin, 48 newborns (51%) of these carriers had the carrier trait and 9 (9.6%) were affected (haemoglobin SC compound heterozigote - HbSC, haemoglobin S homozygote - HbSS). DISCUSSION: These results support the feasibility and usefulness of a selective screening for the detection of haemoglobin variants in high-risk subjects in an area in which sickle cells disease is not endogenous. We achieved the goal of detecting subjects with carrier trait/disease in order to implement preventive measures that reduce the clinical manifestations of sickle cell disease. We are, however, aware that it will be necessary to extend this screening to the overall population in the near future.

Indexed as

Emigration and ImmigrationMass ScreeningAdultAnemia, Sickle CellChild, PreschoolChromatography, High Pressure LiquidErythroblastosis, FetalFemaleHemoglobin, SickleHumansInfantInfant, NewbornItalyMalePilot ProjectsPregnancyHemoglobin, Sickle

Identifiers

PMID24887233
PMCPMC4111816
OpenAlexW209990271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.